Johnson & Johnson has found a private equity firm willing to pay $4.15 billion for its Ortho Clinical Diagnostics division, which provides blood-testing equipment and chemicals. One would think that blood testing should be a booming ...
Tags: Get out of Blood Testing Tech, J&J
Cloud's Meats, Inc., of Carthage, MO, is voluntarily recalling beef and pork products that may possibly be contaminated with E. coli after positive test results in samples of items produced in mid-November. According to a Dec. 2 news ...
Tags: food recall, Cloud's Meats, beef and pork products, E.coli
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may ...
Clearance, an AngioDynamics company, has received the US Food and Drug Administration (FDA) 510(k) clearance for its BioFlo Port with Endexo technology, Clearance to the accumulation of platelets and thrombus. The BioFlo Port is a ...
Sangamo BioSciences has received a $6.4m strategic partnership grant from the California Institute for Regenerative Medicine (CIRM) for the development of ZFP Therapeutic for Beta-thalassemia. The application of its zinc finger nuclease ...
Tags: Sangamo, ZFG Therapeutic
The national healthcare group purchasing organization, Premier Healthcare Alliance, has renewed a 33-month group purchasing agreement with Masimo. Under the agreement, Premier members can take advantage of special pricing and terms ...
Tags: Masimo, Premier Healthcare Alliance, Masimo SET pulse oximetry
Researchers have now moved a step closer to determining new ways to improve quality of life-saving blood transfusions for preterm babies by understanding the mechanism behind the body's inflammatory response. By decreasing the likelihood ...
Tags: blood transfusions, preterm babies, body's inflammatory response, anaemic
The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has recommended Orphan Drug Designation (ODD) for Erytech Pharma's investigational product Enhoxy. The drug, which is used to treat sickle cell ...
Tags: orphan drug designation, Erytech product, debilitating disease